Fiagbedzi Emmanuel, Atuwo-Ampoh Vivian Della, Ofori Ishmael Nii, Nyarko Savanna, Adomako Asare, Hasford Francis, Amlalo Jeffrey Gameli, Gorleku Philip Narteh
Department of Medical Physics, University of Ghana, Accra, Ghana.
Department of Imaging Technology and Sonography, University of Capecoast, Ghana.
Clin Transl Radiat Oncol. 2024 Oct 28;50:100880. doi: 10.1016/j.ctro.2024.100880. eCollection 2025 Jan.
Cervical cancer is an important public health issue with a high incidence and death rate in Africa. It is mostly treated with Brachytherapy as the gold standard but its access is limited. This study set out to investigate the distribution and accessibility of brachytherapy units in Africa for the treatment of cervical cancer, and to provide some recommendations for increasing the quantity and accessibility of such equipment throughout the continent.
The International Atomic Energy Agency's Division of Human Health's Directory for radiotherapy Centers (DIRAC) was the principal source of data for this study. The number of brachytherapy equipment in the 54 African countries was obtained from the DIRAC database. The number of cervical cancer cases was obtained from the GLOBOCAN 2022 database, and country's income was calculated using the Gross Domestic Product (GDP) per capita from the global economics database. All of these searches were conducted in February 2024.
Africa exhibited a greater number of cervical cancer cases. A total of one hundred (100) brachytherapy units were present across 84 radiotherapy centres spanning 20 African countries. Egypt and South Africa each possess 23 units, which accounts for 46% of the overall quantity. With just two brachytherapy facilities, Nigeria had the most cervical cancer cases. A significant quantity of brachytherapy unit was situated in countries of northern Africa. The quantity of these units varied among countries, from those without any to those with many, and was not only influenced by GDP per capita.
Due to the rising incidence of cervical cancer in Africa, the number of brachytherapy equipment was woefully inadequate. Consequently, Africa requires partnerships and financial support to facilitate the quantity and accessibility of brachytherapy services. This will enable the provision of thorough and holistic care to patients and enhance their quality of life.
宫颈癌是一个重要的公共卫生问题,在非洲发病率和死亡率都很高。其主要治疗方法是近距离放射治疗,这是金标准,但这种治疗方法的可及性有限。本研究旨在调查非洲用于治疗宫颈癌的近距离放射治疗设备的分布和可及性,并为在整个非洲大陆增加此类设备的数量和可及性提供一些建议。
国际原子能机构人类健康司的放射治疗中心名录(DIRAC)是本研究的主要数据来源。从DIRAC数据库获取54个非洲国家的近距离放射治疗设备数量。宫颈癌病例数从GLOBOCAN 2022数据库获取,国家收入使用全球经济数据库中的人均国内生产总值(GDP)计算。所有这些搜索均在2024年2月进行。
非洲的宫颈癌病例数较多。在20个非洲国家的84个放射治疗中心共有100个近距离放射治疗设备。埃及和南非各有23个设备,占总数的46%。尼日利亚只有两个近距离放射治疗设施,但宫颈癌病例数最多。大量近距离放射治疗设备位于北非国家。这些设备的数量因国家而异,从没有任何设备到有很多设备,而且不仅受人均GDP影响。
由于非洲宫颈癌发病率不断上升,近距离放射治疗设备数量严重不足。因此,非洲需要伙伴关系和财政支持,以促进近距离放射治疗服务的数量和可及性。这将能够为患者提供全面和整体的护理,并提高他们的生活质量。